1. Safarinejad MR. Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous beta-thalassemia major. Urol 2008; 179: 2327-2332. [
DOI:10.1016/j.juro.2008.01.103]
2. Jensen CE, Abdel-Gadir A, Cox C, Tuck SM, Wonke B. Sperm concentrations and quality in beta-thalassaemia major. Int J Androl 1996; 19: 362-364. [
DOI:10.1111/j.1365-2605.1996.tb00528.x]
3. Perera D, Pizzey A, Campbell A, Katz M, Porter J, Petrou M, et al. Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. Hum Reprod 2002; 17: 1820-1825. [
DOI:10.1093/humrep/17.7.1820]
4. Carpino A, Tarantino P, Rago V, De Sanctis V, Siciliano L. Antioxidant capacity in seminal plasma of transfusion-dependent beta-thalassemic patients. Exp Clin Endocrinol Diabetes 2004; 112: 131-134. [
DOI:10.1055/s-2004-817821]
5. De Sanctis V, Borsari G, Brachi S, Govoni M, Carandina G. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine. Georgian Med News 2008; 156:74-77.
6. De Sanctis V, Perera D, Katz M, Fortini M, Gamberini MR. Spermatozoal DNA damage in patients with B thalassaemia syndromes. Pediatr Endocrinol Rev 2008; 6 (Suppl.): 185-189.